Retatrutide Side Effects The Phase 2 retatrutide trial (Jastreboff et al., NEJM 2023) reported gastrointestinal adverse events as the dominant side-effect pattern, consistent with other GLP-1-class drugs
GLP-1 medications can deplete magnesium through changes in appetite and food intake
PlexusDx's Precision Peptide Genetic Test identifies these 14 metabolic pathways and 49 peptide-related variants, helping you understand whether your regain risk is driven by high genetic predisposition or primarily by behavioral factors that can be modified
It gets into circulation, where it can reach follicles from the blood supply as well as exert broader systemic effects
This version of the medication must be taken on an empty stomach with a small sip of plain water, at least 30 minutes before any other food, drink, or oral medications
Journal of Cachexia, Sarcopenia and Muscle, 15(3), 455468